Tatva Chintan Pharma Chem Limited Incorporated in 1996, Company is a chemical manufacturing company that manufactures structure-directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.
The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.
Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi’s laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.
Competitive Strengths
- Leading manufacturer of structure directing agents and phase transfer catalyst.
- Diversified product portfolio.
- Global market presence with customer base across industries.
- Strategically located manufacturing facility in Gujarat with close proximity to Hazira Port.
- Experienced promoters and managers team.
- Strong financial performance track record.
Tatva Chintan Pharma Chem Ltd IPO Tentative Timetable
| Particular | Date |
| IPO Open Date | 16 July 2021 |
| IPO Close Date | 20 July 2021 |
| Allotment Date | 26 July 2021 |
| IPO Listing Date | 29 July 2021 |
Tatva Chintan Pharma Chem Ltd IPO Details
| Issue Type | Book Built Issue IPO |
| Face Value | Rs. 10 Per Equity Share |
| IPO Price | Rs. 1073 to Rs. 1083 Per Equity Share |
| Market Lot | 13 Share |
| NSE Symbol | |
| BSE Symbol | |
| ISIN Code | |
| Listing At | NSE, & BSE |
| Issue Size | Approx. Rs. 500 Crore. |
Tatva Chintan Pharma Chem Ltd IPO Lot Size
| Application | Lots | Shares | Amount |
| Minimum | 1 | 13 | Rs. 14079 |
| Maximum | 14 | 182 | Rs. 197106 |
Tatva Chintan Pharma Chem Ltd IPO Allotment Status
Click Here To Check IPO Allotment Status Tatva Chintan Pharma Chem Ltd IPO.
Click Here To Get ASBA Forms Tatva Chintan Pharma Chem Ltd IPO.
Company Financials:
| Particular | 31 March 2021 | 31 March 2020 | 31 March 2019 |
| Total Assets | 3148.03 | 2489.38 | 1875.08 |
| Total Revenue | 3062.92 | 2646.22 | 2068.01 |
| Profit After Tax | 522.62 | 377.89 | 205.43 |
Company Promoters:
Ashok Ramnarayan Boob, Krishnakumar Ramnarayan Boob, Siddhartha Ashok Sikchi, and Parth Ashok Maheshwari are the company promoters.
Objects of this Issue:
The net IPO proceeds will be used for the following purposes;
- To make an offer for sale of equity shares aggregating to Rs. 1,5466.22 million.
- To achieve the share listing benefits on the BSE and NSE.
Registrar & Company Details
| Company Contact Information | IPO Registrar |
| Tatva Chintan Pharma Chem Ltd Plot No. 502 / 17, GIDC Estate, Ankleshwar, Bharuch, Gujarat – 393002, India Phone: +91 75730 46951 Email: cs@tatvachintan.com Website: http://www.tatvachintan.com/ | Link Intime India Private Ltd C 101, 247 Park, L.B.S.Marg, Vikhroli (West), Mumbai – 400083 Phone: +91-22-4918 6270 Email: cleanscience.ipo@linkintime.co.in Website: http://www.linkintime.co.in |
